1. Home >
  2. M&A >
  3. Recapitalization >
  4. United States >
  5. New York >
  6. Arsenal Capital Partners Acquires BioIVT

M&A Deal Summary

Arsenal Capital Partners Acquires BioIVT

On January 5, 2016, private equity firm Arsenal Capital Partners acquired life science company BioIVT from Thompson Street Capital Partners

Acquisition Highlights
  • This is Arsenal Capital Partners’ 3rd transaction in the Life Science sector.
  • This is Arsenal Capital Partners’ 29th transaction in the United States.
  • This is Arsenal Capital Partners’ 3rd transaction in New York.
Investment Fate
  • BioIVT was sold to a consortium of financial buyers in 2021.

M&A Deal Summary
Date 2016-01-05
Target BioIVT
Sector Life Science
Buyer(s) Arsenal Capital Partners
Sellers(s) Thompson Street Capital Partners
Deal Type Recapitalization

Target

BioIVT

Hicksville, New York, United States
BioIVT is a provider of biological products to life sciences and pharmaceutical companies. BioIVT specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT was founded in 1981 and is based in Hicksville, New York.

Search 205,333 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Arsenal Capital Partners

New York, New York, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.

DEAL STATS #
Overall 30 of 57
Sector (Life Science) 3 of 6
Type (Recapitalization) 2 of 4
State (New York) 3 of 3
Country (United States) 29 of 50
Year (2016) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-06-30 PSG

Cleveland, Ohio, United States

PSG is a manufacturer of proprietary and custom polymer additives, dispersions, and performance chemicals for the rubber, plastic, and engineered wood industries. PSG offers a variety of customer-centric solutions that improve polymer processing, increase surface protection, and enhance product performance. PSG was founded in 2015 and is based in Cleveland, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-06 CoolSys

Brea, California, United States

CoolSys is a refrigeration and HVAC services company, specializing in a full spectrum of best-in-class service experiences and solutions for customers in the retail, food service, commercial and industrial market segments. CoolSys was founded in 2001 and is based in Brea, California.

Sell -

Seller(S) 1

SELLER

Thompson Street Capital Partners

St. Louis, Missouri, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Thompson Street Capital Partners is a private equity firm that targets control stakes in profitable, mid-sized North American companies with $5 to $20 million of EBITDA. Thompson Street looks for family businesses, private companies seeking liquidity, corporate divestitures, and public companies going private. Areas of interest include healthcare services, business services, electronics, information technology, and engineered products companies. Thompson Street will not consider investments in start-ups, early stage companies, or real estate. Thompson Street Capital was founded in 2000 and is based in St. Louis, Missouri.

DEAL STATS #
Overall 18 of 47
Sector (Life Science) 1 of 2
Type (Recapitalization) 2 of 2
State (New York) 2 of 6
Country (United States) 18 of 47
Year (2016) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-14 FocusVision

New York, New York, United States

FocusVision offers a comprehensive suite of experience insights software solutions including advanced surveys, online interviews, and focus groups, and online qualitative research community solutions to get brands close enough to their customers to have a full understanding of Customer Truth how they think, feel, and act. FocusVision was founded in 1990 and is based in New York City.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-04 Vaddio

New Hope, Minnesota, United States

Vaddio LLC is a developer, manufacturer and distributor of advanced robotic cameras, sophisticated camera control systems, high definition video whiteboards and complementary audiovisual accessory products.

Sell -
Mergr

Product

Company

Legal